Passage Bio, Inc. (PASG) Tops Q2 EPS by 5c

Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.26), $0.05 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Accenture (ACN) spreader of 22700 contracts of August 120 puts and 22200 contracts of August 130 calls as share price down 7.2%
• Visteon (VC) 354 contracts of June 120 calls as share price up 6%